Home » Biocon, Optimer in Pact to Supply, Make Fidaxomicin
Biocon, Optimer in Pact to Supply, Make Fidaxomicin
Biocon and Optimer Pharmaceuticals said on Monday they have signed a long-term supply agreement to manufacture Fidaxomicin, an antibiotic used to treat clostridium difficile infection.
The Economic Times
The Economic Times
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May